74
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer

, , , , , , , , & show all
Pages 6913-6927 | Published online: 30 Oct 2018

References

  • SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
  • NakazawaMPallerCKyprianouNMechanisms of therapeutic resistance in prostate cancerCurr Oncol Rep2017192133328229393
  • ClementJMSweeneyCJEvolving treatment of oligometastatic Hormone-Sensitive prostate cancerJ Oncol Pract201713191828045610
  • GinnSLAlexanderIEEdelsteinMLAbediMRWixonJGene therapy clinical trials worldwide to 2012 – an updateJ Gene Med2013152657723355455
  • MarangoniKNevesAFRochaRMProstate-specific RNA aptamer: promising nucleic acid antibody-like cancer detectionSci Rep20155121134
  • LiHMohamedAASharadSSilencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTENOncotarget2015617151371514925883222
  • FournierPGJuárezPJiangGThe TGF-β signaling regulator PMEPA1 suppresses prostate cancer metastases to boneCancer Cell201527680982125982816
  • VazquezERoldánMDiez-GilCProtein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptideNanomedicine20105225926820148637
  • FutakiSHiroseHNakaseIArginine-rich peptides: methods of translocation through biological membranesCurr Pharm Des201319162863286823140459
  • YaoCLiuJWuXReducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapyJ Control Release201623220321427126903
  • LiuHWangHYangWChengYDisulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low costJ Am Chem Soc201213442176801768723050493
  • TaiZWangXTianJBiodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivoBiomacromolecules20151641119113025686200
  • KimTIOuMLeeMKimSWArginine-grafted bioreducible poly(disulfide amine) for gene delivery systemsBiomaterials200930465866419007981
  • WonYWYoonSMLeeKMKimYHPoly(oligo-D-arginine) with internal disulfide linkages as a cytoplasm-sensitive carrier for siRNA deliveryMol Ther201119237238021081902
  • ChengRFengFMengFDengCFeijenJZhongZGlutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene deliveryJ Control Release2011152121221295087
  • SonSNamgungRKimJSinghaKKimWJBioreducible polymers for gene silencing and deliveryAcc Chem Res20124571100111222129162
  • LowSAYangJKopečekJBone-targeted acid-sensitive doxorubicin conjugate micelles as potential osteosarcoma therapeuticsBioconjug Chem201425112012202025291150
  • JiangTYuXCarboneEJNelsonCKanHMLoKWPoly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applicationsInt J Pharm20144751–254755725194353
  • OhSKimBJSinghNPLaiHSasakiTSynthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptideCancer Lett20092741333918838215
  • DanielsTRDelgadoTHelgueraGPenichetMLThe transferrin receptor part II: targeted delivery of therapeutic agents into cancer cellsClin Immunol2006121215917616920030
  • LeeJHEnglerJACollawnJFReceptor mediated uptake of peptides that bind the human transferrin receptorFebs J2010268720042012
  • HanLLiJHuangSPeptide-conjugated polyamidoamine den-drimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agentBiomaterials201132112989299821277017
  • KuangYAnSGuoYT7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targetingInt J Pharm20134541112023867728
  • HavensAMPedersenEAShiozawaYAn in vivo mouse model for human prostate cancer metastasisNeoplasia2008104371–IN418392141
  • KimTIOuMLeeMKimSWArginine-grafted bioreducible poly(disulfide amine) for gene delivery systemsBiomaterials200930465866419007981
  • GaumetMVargasAGurnyRDelieFNanoparticles for drug delivery: the need for precision in reporting particle size parametersEur J Pharm Biopharm20086911917826969
  • HanLHuangRLiuSHuangSJiangCPeptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumorsMol Pharm2010762156216520857964
  • FengSZhuXFanBXieDLiTZhangXmiR-19a-3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasionMol Med Rep20161354030403827035427
  • ChoHJYoonISYoonHYPolyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicinBiomaterials20123341190120022074664